28
Feb
Unraveling the Complexity of Cardiovascular Health: The Crucial Role of Comprehensive Lipid Testing
Cardiovascular disease (CVD) remains the leading cause of death in the U.S. and the world. Identifying and managing risk factors for CVD is essential in preventing its onset and progression. One critical aspect of cardiovascular risk assessment is lipid testing, which provides insights into an individual’s lipid profile, aiding in personalized treatment strategies. While testing blood levels of cholesterol and triglycerides has been a mainstay in the diagnosis and management of CVD for well over 35 years, recent research has demonstrated that there are many other factors which should also be considered.
Understanding Basic Lipid Testing:
Lipids, including cholesterol and triglycerides, are essential components of cell membranes and play a vital role in the body’s physiological functions. However, an imbalance in lipid levels, specifically elevated levels of low-density lipoprotein cholesterol (LDL-C), is a well-established risk factor for CVD and is thought to be responsible for the formation of plaques in the arteries, which can lead to narrowing of the arteries, and may result in a heart attack. Comprehensive lipid testing can now go beyond measuring cholesterol levels to include assessing various lipid fractions, providing a more nuanced view of an individual’s cardiovascular risk. Today, we can use newer tools which allow us to consider not only LDL-C and high-density lipoprotein cholesterol (HDL-C), the “good” cholesterol, but also to assess many other factors which all may contribute to cardiovascular disease.
The Role of LDL-C:
LDL-C, often referred to as “bad cholesterol,” is a primary contributor to atherosclerosis, the underlying cause of most CVDs. While traditional lipid panels focus on LDL-C, recent studies emphasize the need for a more comprehensive approach. Targeting specific LDL subtypes and assessing the functional quality of LDL particles can provide a more accurate representation of an individual’s risk.
Beyond LDL-C: Non-HDL-C and Triglycerides:
Non-HDL-C, calculated as total cholesterol minus HDL-C, is thought to represent all atherogenic (plaque-forming) lipoproteins. This parameter serves as a reliable indicator of cardiovascular risk, especially in individuals with elevated triglyceride levels. Triglycerides, another crucial component of the lipid profile, are associated with increased risk when elevated, emphasizing the need for their inclusion in comprehensive lipid testing. Recently, research has focused on several other parameters which may be even more important than LDL-C levels in determining cardiovascular risk. These include lipoprotein(a), apolipoprotein B, LDL particle number, and LDL particle size.
Comprehensive lipid testing is indispensable in the assessment and management of cardiovascular risk. New research has shed light on the evolving landscape of lipid testing, emphasizing the need to move beyond traditional measures. By considering not only LDL-C, non-HDL-C, and triglycerides, but also lipoprotein(a), apolipoprotein B, LDL particle number, and LDL particle size, healthcare professionals can develop more accurate risk assessments, enabling personalized strategies for preventing and managing cardiovascular diseases.
Stay informed, stay healthy.
References:
Björnson E, Adiels M, Taskinen MR, et al. Lipoprotein(a) Is Markedly More Atherogenic Than LDL: An Apolipoprotein B-Based Genetic Analysis. J Am Coll Cardiol. 2024 Jan 23;83(3):385-395. doi: 10.1016/j.jacc.2023.10.039. PMID: 38233012.
Xiao L, Zhang K, Wang F, et al. The LDL-C/ApoB ratio predicts cardiovascular and all-cause mortality in the general population. Lipids Health Dis. 2023 Jul 21;22(1):104. doi: 10.1186/s12944-023-01869-1. PMID: 37480052; PMCID: PMC10362700.
Quesada JA, Bertomeu-González V, Orozco-Beltrán D, et al. The benefits of measuring the size and number of lipoprotein particles for cardiovascular risk prediction: A systematic review and meta-analysis. Clin Investig Arterioscler. 2023 Jul-Aug;35(4):165-177. English, Spanish. doi: 10.1016/j.arteri.2022.11.001. PMID: 36522243.
